Authors:
Huang, YS
Luedtke, RR
Freeman, RA
Wu, L
Mach, RH
Citation: Ys. Huang et al., Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D-2 and D-3 receptors, BIO MED CH, 9(12), 2001, pp. 3113-3122
Authors:
Huang, YS
Luedtke, RR
Freeman, RA
Wu, L
Mach, RH
Citation: Ys. Huang et al., Synthesis and structure-activity relationships of naphthamides as dopamineD-3 receptor ligands, J MED CHEM, 44(11), 2001, pp. 1815-1826
Authors:
Martin, MW
Scott, AW
Johnston, DE
Griffin, S
Luedtke, RR
Citation: Mw. Martin et al., Typical antipsychotics exhibit inverse agonist activity at rat dopamine D1-like receptors expressed in Sf9 cells, EUR J PHARM, 420(2-3), 2001, pp. 73-82
Authors:
Luedtke, RR
Freeman, RA
Boundy, VA
Martin, MV
Huang, YS
Mach, RH
Citation: Rr. Luedtke et al., Characterization of I-125-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors, SYNAPSE, 38(4), 2000, pp. 438-449
Authors:
Mach, RH
Hammond, PS
Huang, YS
Yang, BO
Xu, YP
Cheney, JT
Freeman, R
Luedtke, RR
Citation: Rh. Mach et al., Structure-activity relationship studies of N-(9-benzyl)-9-azabicyclo[3.3.1]nonan-3-beta-yl benzamide analogues for dopamine D-2 and D-3 receptors, MED CHEM RE, 9(6), 1999, pp. 355-373
Authors:
Hammond, PS
Cheney, JT
Johnston, DE
Ehrenkaufer, RL
Luedtke, RR
Mach, RH
Citation: Ps. Hammond et al., Synthesis, in vitro dopamine D-2 and D-3 receptor binding and quantitativestructure-activity studies on substituted 2,3-dimethoxy-N-(1-benzyl-4-piperidinyl)benzamides and related compounds., MED CHEM RE, 9(1), 1999, pp. 35-49
Authors:
Luedtke, RR
Griffin, SA
Conroy, SS
Jin, XL
Pinto, A
Sesack, SR
Citation: Rr. Luedtke et al., Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes, J NEUROIMM, 101(2), 1999, pp. 170-187